Roberto P. Santos is a professor of pediatrics at the University of Mississippi Medical Center and an attending pediatric infectious diseases physician at the Children’s of Mississippi. He currently heads…
PIDS was one of 20 organizations to sign on to the Council of Pediatric Subspecialties (CoPS) policy brief concerning Legislative Priorities for Developing the Next Generation of Diverse Child Health…
I’ve always had a soft spot for idioms and maxims. My dad’s go-to phrase was “well, if a frog had wings, it wouldn’t bump its butt every time it hopped.”…
In a story by Reuters, data from UNICEF and WHO show cases of measles jumped 79% in the first two months of 2022 compared to 2021. Reported cases for January…
CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…
Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…
Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…
Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…
A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…
It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…
Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…
On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…